Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)
09/01/2023 - 07/31/2028 (Subcontract PI)
PI:
Julien Dedier, MD, MPHThe General Hospital Corporation / MGH NIH NIAMS
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications04/17/2021 - 06/30/2025 (Subcontract PI)
PI:
Julien Dedier, MD, MPHDuke Clinical Research Institute NIH NCATS3U24TR001608-05S4
Multilevel Physical Activity Intervention for Low Income Public Housing Residents03/01/2024 - 04/30/2025 (Subcontract PI)
PI:
Julien Dedier, MD, MPHTufts University NIH NIMHD
Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST) Subaward09/01/2023 - 07/31/2024 (Subcontract PI)
PI:
Julien Dedier, MD, MPHMassachusetts General Hospital NIH NIAMS1U01AR080985-01A1
A Culturally-Adapted Automated System to improve Blood Pressure Control Through Exercise09/01/2009 - 03/31/2013 (PI)
Robert Wood Johnson Foundation
Ethnic identity as a target for tailored cancer prevention interventions09/01/2007 - 02/28/2013 (PI)
American Cancer Soc